What is BioElectronics?
Founded in 2000, BioElectronics operates at the intersection of advanced engineering and clinical healthcare. The company specializes in the manufacturing and retailing of sophisticated electro-medical devices, providing non-invasive alternatives for chronic pain management. With its headquarters in Frederick, Maryland, the organization has established a durable footprint in the medical technology landscape, focusing on patient-centric solutions that address the growing demand for drug-free therapeutic interventions. Their business model integrates rigorous research and development with scalable manufacturing processes, ensuring that their proprietary technology remains at the forefront of the pain management industry.
How much funding has BioElectronics raised?
BioElectronics has raised a total of $112K across 1 funding round:
Debt
$112K
Debt (2021): $112K with participation from PPP
Key Investors in BioElectronics
PPP
Public-Private Partnership
What's next for BioElectronics?
With the successful closure of this late-stage financing, BioElectronics is strategically positioned to scale its operational infrastructure and expand its distribution networks. The infusion of capital will likely be directed toward enhancing product efficacy, navigating complex regulatory landscapes, and broadening the reach of their electro-medical solutions to international markets. As the company transitions into this next phase of growth, the focus will remain on maintaining its competitive advantage through innovation and strategic partnerships, ultimately aiming to solidify its status as a leader in the electro-medical device market.
See full BioElectronics company page
